Angiogenesis in B Cell Lymphoproliferative Diseases. Biological and Clinical Studies

References

• Hudlicka O. Development of microcirculation: capillary growth and adaptation. In. Handbook of Physiology, Section 2. The Cardiovascular System. Vol. IV. Microcirculation Part 1984; 1, pp 155–216. Baltimore: Waverly Press
   Google Scholar
• D'Amore P. A. Mechanisms of endothelial growth control. Am. J. Respir. Cell Mol. Biol. 1992; 6: 1–8
   PubMed Web of Science ®Google Scholar
• Ingher D. E., Folkman J. How does extracellular matrix control capillary morphogenesis?. Cell 1989; 58: 803–5
   PubMed Web of Science ®Google Scholar
• Gross J. L., Moscatelli D., Rifkin D. B. Increased capillary endothelial cell protease activity in response to angiogenic stimuli. in vitro. Proc. Natl. Acad. Sci. USA 1983; 80, 2623–7
   Web of Science ®Google Scholar
• Ausprunk D. H., Folkman J. Migration and proliferation of endothelial cells in preformed and newly formed blood vessels during tumor angiogenesis. Microvasc. Res. 1977; 14: 53–65
   PubMed Web of Science ®Google Scholar
• Paku S., Paweletz N. First steps of tumor related angiogenesis. Lab. Invest. 1991; 65: 334–46
   PubMed Web of Science ®Google Scholar
• Ribatti D., Vacca A., Roncali L., Dammacco F. Angiogenesis under normal and pathological conditions. Haematologica 1991; 76: 311–20
   PubMed Web of Science ®Google Scholar
• Folkman J. What is the evidence that tumors are angiogenesis dependent?. J. Natl. Cancer Inst. 1990; 82: 4–6
   PubMed Web of Science ®Google Scholar
• Sutherland R. M., Mc Credie J. A., Inch W. R. Growth of multicell spheroids in tissue culture as a model of nodular carcinomas. J. Natl. Cancer Inst. 1971; 46: 113–7
   PubMed Web of Science ®Google Scholar
• Gimbrone M. A., Leapman S., Cotran R. S., Folkman J. Tumor dormancy in vivo by prevention of neovascularization. J. Exp. Med. 1972; 136: 261–7
   PubMed Web of Science ®Google Scholar
• Salmon S. E., Seligman M. B-cell neoplasia in man. Lancet 1974; ii: 1230–3
   Google Scholar
• Shackney S. E., Levine A. M., Fisher R. I., Nichols P., Jaffe E., Schuette W. H., Simon R., Smith C. A., Occhipinti S. J., Parker J. W., Cossman J., Young R. C., Lukes R. J. The biology of tumor growth in the non-Hodgkin's lymphomas. A dual parameter flow cytometry study of 220 cases. J. Clin. Invest. 1984; 7: 1201–14
   Web of Science ®Google Scholar
• Folkman J. Tumor angiogenesis. Adv. Cancer Res. 1985; 43: 175–203
   PubMed Web of Science ®Google Scholar
• Folkman J., Grenspan H. P. Influence of geometry on control of cell growth. Biochem. Biophys. Acta 1975; 417: 211–36
   PubMed Web of Science ®Google Scholar
• Tannock I. F. The relation between cell proliferation and the vascular system in a transplanted mouse mammary tumor. Brit. J. Cancer 1968; 22: 258–73
   PubMed Web of Science ®Google Scholar
• Folkman J., Watson K., Ingber D., Hanahan D. Induction of angiogenesis during the transition from hyperplasia to neoplasia. Nature 1989; 339: 58–61
   PubMed Web of Science ®Google Scholar
• Folkman J. Angiogenesis and breast cancer. J. Clin. Oncol. 1994; 12: 441–3
   PubMed Web of Science ®Google Scholar
• Billadeau D., Ahmann G., Greipp P., Van Ness B. The bone marrow of multiple mycloma patients contains B cell populations at different stages of differentiation that are clonally related to malignant plasma cell. J. Exp. Med. 1993; 178: 1023–31
   PubMed Web of Science ®Google Scholar
• Drewinko B., Alexanian R., Boyer H., Barlogie B., Rubinow S. I. The growth fraction of human myeloma cells. Blood 1981; 57: 333–8
   PubMed Web of Science ®Google Scholar
• Durie B. G. M., Salmon S. E. High speed scintillation autoradiography. Science 1975; 190: 1093–5
   PubMed Web of Science ®Google Scholar
• Durie B. G. M., Salmon S. E., Moon T. E. Pretreatment tumor mass, cell kinetics, and prognosis in multiple myeloma. Blood 1980; 55: 364–72
   PubMed Web of Science ®Google Scholar
• Greipp P. R., Kyle R. A. Clinical, morphological, and cell kinetic differences among multiple myeloma, monoclonal gammopathy of undetermined significance, and smoldering multiple myeloma. Blood 1983; 62: 166–71
   PubMed Web of Science ®Google Scholar
• Ucci G., Riccardi A., Dormer P., Danova M., Luoni R., Montecucco C. M., Ciotti R., Girino M. Proliferation kinetics of plasma cells and of normal haemopoietic cells in multiple myeloma. Cell Tissue Kinet. 1987; 20: 311–8
   PubMedGoogle Scholar
• Durie B. G. M. Staging and kinetics of multiple myeloma. Semin. Oncol. 1986; 13: 300–9
   PubMed Web of Science ®Google Scholar
• Salmon S. E. Expansion of growth fraction in multiple myeloma with alkylating agents. Blood 1975; 45: 119–29
   PubMed Web of Science ®Google Scholar
• Diamond L. W., Nathwani B. N., Rappaport H. Flow cytometry in the diagnosis and classification of malignant lymphoma and leukemia. Cancer 1982; 50: 1122–35
   PubMed Web of Science ®Google Scholar
• Wain S. L., Braylan P. C., Borowitz M. J. Correlation of monoclonal antibody phenotyping and cellular DNA content in non-Hodgkin's lymphoma. The Southeastern Cancer Study Group Experience. Cancer 1987; 60: 2403–11
   PubMed Web of Science ®Google Scholar
• Joensuu H., Klemi P. J., Jalkanen S. Biologic progression in non-Hodgkin's lymphoma. Cancer 1990; 65: 2564–71
   PubMed Web of Science ®Google Scholar
• Del Vecchio M. T., Leoncini L., Buerki K., Kraft R., Megha T., Barbini P., Tosi P., Cottier H. Diffuse centrocyte and/or centroblastic malignant non-Hodgkin's lymphomas: comparison of mitotic and pyknotic (apoptotic) indices. Int. J. Cancer 1991; 47: 38–43
   PubMed Web of Science ®Google Scholar
• Vacca A., Ribatti D., Roncali L., Ranieri G., Serio G., Silvestris F., Dammacco F. Bone marrow angiogenesis and progression in multiple myeloma. Brit. J. Haematol. 1994; 87: 503–8
   PubMed Web of Science ®Google Scholar
• Vacca A., Ribatti D., Roncali L., Lospalluti M., Serio G., Carrel S., Dammacco F. Melanocyte tumor progression is associated with changes in angiogenesis and expression of the 67-kilodalton laminin receptor. Cancer 1993; 72: 455–61
   PubMed Web of Science ®Google Scholar
• Nguyen M., Watanabe H., Budson A., Richie J. P., Hayes D. F., Folkman J. Basic fibroblast growth factor (bFGF) is elevated in the urine of patients with a wide variety of neoplasms. Mol. Biol. Cell 1992; 3: 234A
   Web of Science ®Google Scholar
• Folkman J., Shing Y. Angiogenesis. J. Biol. Chem. 1992; 267: 10931–4
   PubMed Web of Science ®Google Scholar
• Miyazono K., Usuki K., Heldin C. H. Platelet-derived endothelial cell growth factor. Progr. Growth Factor Res. 1991; 3: 207–17
   PubMedGoogle Scholar
• Senger D. R., Galli S. J., Dvorak A. M., Perruzzi C. A., Harvey V. S. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascite fluid. Science 1983; 219: 983–5
   PubMed Web of Science ®Google Scholar
• Tsao M. S., Zhu H., Giad A., Viallet J., Nakamura T., Park M. Hepatocyte growth factor/scatter factor is an autocrine factor for human normal bronchial epithelial and lung carcinoma cells. Cell Growth Differ. 1993; 4: 571–9
   PubMedGoogle Scholar
• Herlyn M., Clark W. H., Rodeck U., Mancianti M. L., Jambrosic J., Koprowski H. Biology of tumor progression in human melanocytes. Lab. Invest. 1987; 56: 461–74
   PubMed Web of Science ®Google Scholar
• Mantovani A. Tumor-associated macrophages in neoplastic progression: a paradigm for the in vivo function of chemokines. Lab. Invest. 1994; 71: 5–16
   PubMed Web of Science ®Google Scholar
• Leibovich S., Polverini S. J., Shepard H. M., Wiseman D. M., Shively V., Nusseir N. Macrophage-induced angiogenesis mediated by tumor necrosis factor alpha. Nature 1987; 329: 630–2
   PubMed Web of Science ®Google Scholar
• Koch A. E., Polverini P. J., Kunkel S. L., Harlow L. A., Di Pietro L. A., Einer S. G., Strieter R. M. Interleukin-8 as a macrophage-derived mediator of angiogenesis. Science 1992; 258: 1178–81
   Web of Science ®Google Scholar
• Benezra D., Hemo I., Maftzir G. In vivo angiogenic activity of interleukins. Arch. Ophthal. 1990; 108: 573–6
   PubMed Web of Science ®Google Scholar
• Motro B., Itin A., Sachs L., Keshet E. Pattern of interleukin 6 gene expression in vivo suggests a role for this cytokine in angiogenesis. Proc. Natl. Acad. Sci. USA 1990; 87: 4068–72
   PubMed Web of Science ®Google Scholar
• Bussolino F., Ziche M., Wang J. M., Alessi D., Morbidelli L., Cremona O., Bosia A., Marchisio P. C., Mantovani A. In vitro and in vivo activation of endothelial cells by colony stimulating factors. J. Clin. Invest. 1991; 87: 986–95
   PubMed Web of Science ®Google Scholar
• Kandel J., Bossy-Wetzel E., Raduvanyi F., Klasgsbrun M., Folkman J., Hanahan D. Neovascularization is associated with a switch to the export of bFGF in the multistep development of fibrosarcoma. Cell 1991; 66: 1095–104
   PubMed Web of Science ®Google Scholar
• Pepper M. S., Vassalli J. D., Wilks J. W., Schweigerer L., Orci L., Montesano R. Modulation of bovine microvascular endothelial cell proteolytic properties by inhibitors of angiogenesis. J. Cell Biochem. 1994; 55: 419–34
   PubMed Web of Science ®Google Scholar
• Rastinejad F., PolverÍNi P. J., Bouk N. P. Regulation of the activity of a new inhibitor of angiogenesis by a cancer suppressor gene. Cell 1989; 56: 345–55
   PubMed Web of Science ®Google Scholar
• Dameron K. M., Volpert O. V., Tainsky M. A., Bouck N. Control of angiogenesis in fibroblast by p53 regulation of thrombospondin-1. Science 1994; 265, 1582–4
   PubMed Web of Science ®Google Scholar
• Barlogie B., Epstein J., Selvanayagam P., Alexanian R. Plasma cell myeloma. New biological insights and advances in therapy. Blood 1989; 73: 865–79
   PubMed Web of Science ®Google Scholar
• Merico F., Bergui L., Gregoretti M. G., Ghia P., Aimo G., Lindley I. J. D., Caligaris-Cappio F. Cytokines involved in the progression of multiple myeloma. Clin. Exp. Immunol. 1993; 92: 27–31
   PubMed Web of Science ®Google Scholar
• Portier M., Zhang X. G., Ursule E., Lees D., Jourdan M., Bataillle R., Klein B. Cytokine gene expression in human multiple myeloma. Brit. J. Haematol. 1993; 85: 514–20
   PubMed Web of Science ®Google Scholar
• Mostava L. K., Jones D. B., Wright D. H. Mechanism of the induction of angiogenesis by human neoplastic lymphoid tissue: studies on the chorioallantoic membrane (CAM) of the chick embryo. J. Pathol. 1980; 132: 191–205
   PubMed Web of Science ®Google Scholar
• Ribatti D., Vacca A., Bertossi M., De Benedictis G., Roncali L., Dammacco F. Angiogenesis induced by B-cell non-Hodgkin's lymphomas. Lack of correlation with tumor malignancy and immunologic phenotype. Anticancer Res. 1990; 10: 401–6
   PubMed Web of Science ®Google Scholar
• Francia Di Celle P., Carbone A., Marchis D., Zhou D., Sozzani S., Zupo S., Pini M., Mantovani A., Foa R. Cytokine gene expression in B-cell lymphocytic leukemia: evidence of constitutive IL-8 mRNA expression and secretion of biologically active IL-8 protein. Blood 1994; 84: 220–8
   PubMed Web of Science ®Google Scholar
• Blotnik S., Peoples G. E., Freeman M. R., Eberlein T. J., Klagsbrun M. T-lymphocytes synthesize and export heparin-binding epidermal growth factor-like growth factor and basic fibroblast growth factor, mitogens for vascular cells and fibroblasts: differential production and release by CD4+ and CD8+ cells. Proc. Natl. Acad. Sci. USA 1994; 91: 2890–4
   PubMed Web of Science ®Google Scholar
• Boccadoro M., Marmont F., Tribalto M., Fossati G., Redoglia V., Battaglio S., Massaia M., Gallamini A., Comotti B., Barbui T., Campobasso N., Dammacco F., Cantonetti M., Petrucci M. T., Mandelli F., Resegotti L., Pileri A. Early responder myeloma: kinetic studies identify a patient subgroup characterized by very poor prognosis. J. Clin. Oncol. 1989; 7: 119–25
   PubMed Web of Science ®Google Scholar
• Weidner N., Semple J. P., Welch W. R., Folkman J. Tumor angiogenesis and metastasis. Correlation in invasive breast carcinoma. N. Engl. J. Med. 1991; 324: 1–8
   PubMed Web of Science ®Google Scholar
• Macchiarini P., Fontanini G., Hardin M. J., Squartini F., Angeletti C. A. Relation of neovascularization to metastasis of non-small-cell lunge cancer. Lancet 1992; 340: 145–6
   PubMed Web of Science ®Google Scholar
• Weidner N., Carroll P. R., Flax D., Blumenfeed W., Folkman J. Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma. Am. J. Pathol. 1993; 143: 401–9
   PubMed Web of Science ®Google Scholar
• Holte H., Lange Davis C., Beiske K., Stokke T., Marton P. F., Smeland E. B., Hoie J., Kvaloy S. Ki67 and 4F2 antigen expression as well as DNA synthesis predict survival at relapse/tumor progression in low-grade B-cell lymphoma. Int. J. Cancer 1989; 44: 975–80
   PubMed Web of Science ®Google Scholar
• Ribatti D., Vacca A., Bertossi M., Roncali L. Anti-angiogenesis: a multipurpose therapeutic tool?. Int. J. Clin. Lab. Res. 1993; 23: 117–20
   PubMedGoogle Scholar
• Folkman J. Diagnostic and therapeutic applications of angiogenesis research. C. R. Acad. Sci. Paris/Sciences de la vie 1994; 316: 914–8
   Web of Science ®Google Scholar